3D Bioprinting Market

3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser), Bioink (Natural, Synthetic, Hybrid)), Material (Hydrogel, Living Cells), Application (Skin, Drug Research), End user (Biopharma, Academia) - Global Forecast to 2024

Report Code: BT 4971 Sep, 2019, by marketsandmarkets.com

[183 Pages Report] The 3D bioprinting market is projected to reach USD 1,647.4 million by 2024 from USD 651.6 million in 2019, at a CAGR of 20.4% from 2019 to 2024. The growth of the 3D bioprinting market is mainly driven by the technological advancements in 3D bioprinters and biomaterials, increasing use of 3D bioprinting in the pharmaceutical and cosmetology industries, and rising public and private funding to support bioprinting research activities. These factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities, especially in emerging markets, which are expected to witness the highest growth.

3D Bioprinting Market Dynamics

By application, the 3D bioprinting market for the skin printing applications segment is expected to grow at the highest growth rate during the forecast period

The clinical applications market is further segmented into skin printing, bone & cartilage printing, blood vessel printing, and other clinical applications. Among these, the skin printing applications segment is estimated to grow at the highest CAGR of 19.8% during the forecast period. This can be attributed to the technological advancements and new product launches in this application segment, and the growing number of aesthetic and reconstruction surgeries across the globe.

By material, the living cells segment is expected to hold the largest market share during the forecast period

On the basis of material, the 3D bioprinting market is segmented into hydrogels, extracellular matrices, living cells, and other biomaterials. In 2018, the living cells segment accounted for the largest market share primarily due to the growing R&D in the fields of regenerative medicine and stem cell research, and increasing public and private investments to support research.

3D Bioprinting Market Dynamics

APAC is estimated to grow at the highest growth rate during the forecast period.

The Asia Pacific market is estimated to grow at the highest CAGR of 23.1% during the forecast period, driven by the increasing research activities, growing demand for organ transplants, an increasing number of initiatives by market players for expanding their presence in the APAC, and higher adoption of stem cell research in several APAC countries. China and India are expected to offer significant growth opportunities for players operating in the 3D bioprinting market, owing to the growing support from government bodies, increasing demand for cosmetic surgeries, and the presence of less-stringent regulations and data requirements (as compared to developed countries) in their respective healthcare systems.

Market Dynamics

Driver:  Technological advancements in the 3D bioprinting industry

Over the years, 3D bioprinting technology has witnessed increased adoption in the healthcare industry. Bioprinting has emerged as a promising technology for the fabrication of artificial tissues and organs, which can revolutionize the diagnosis and treatment of various medical conditions. Bioprinting companies around the world are continuously innovating in regenerative medicine, tissue engineering, drug therapies, and stem cell therapy, which is gaining attention from healthcare professionals and pharmaceutical companies to envision a future with better patient care, customized medical treatment, and an alternative to organ transplantation.

Over the past few years, major technological advancements in the 3D bioprinting space have taken place for several medical applications, including skin tissue development, cancer therapeutics, bone and cartilage development, and liver modeling. Advanced technologies provide players with a competitive edge and thereby help in strengthening their position and share in the market. For instance, in 2018, Poietis (France) launched the 3D bioprinted skin model, Poieskin. The total human skin model is made by the bioprinting of primary human collagen and fibroblast for the dermal layer and primary human keratinocytes for the epidermal layer.

Restraint:  Dearth of skilled professionals

3D bioprinting is an emerging field in the healthcare industry and is witnessing continuous technological advancements, which is leading to the increased demand for skilled professionals who can effectively operate these systems. The effective use of 3D bioprinting technology requires continuous process monitoring. The consistency of the process varies in different platforms due to uncontrolled process variables (such as the difference between batches and machines) and material differences. These technologies and processes require the skills of a trained professional who can understand and operate the 3D bioprinter efficiently.

The most important aspect of the 3D printing service is the skill of spatial object design. Designing a 3D-printed object is more complicated than actually printing the object. Likewise, 3D printed models have complex geometrical structures, which require technical support for printing with a material that offers high shrinkage. Thus, skilled professionals are required to perform these activities in order to avoid errors and printing failure. Also, the biggest challenge faced by the 3D bioprinting industry is the use of multiple technologies. This has resulted in the increased demand for highly skilled personnel to handle operations and troubleshoot activities during 3D bioprinting procedures.

Opportunity: Growing Demand for regenerative medicine & stem cell research

Increasing stem cell research activities and financial support from several public-private organizations are driving the growth of the stem cell and regenerative medicine industry across the globe. A supportive regulatory environment in emerging countries, the presence of a large number of stem cell product pipelines, and applications of regenerative medicine in treating diseases are the key factors contributing to the increasing adoption of stem cell and regenerative medicine worldwide. 3D bioprinting is used in various applications in regenerative medicine. It is used in the development of body parts such as cartilage, heart, and liver, among other organs, for the treatment of different disease conditions. Likewise, stem cells are also used on a large scale for bioprinting different bones and tissues. These cells can adapt easily to growth factors and develop into the required 3D structures.

Challenge:  Socioethical concerns related to the use of 3D bioprinted products

3D bioprinting makes use of living cells for the development of products used in a wide range of medical applications. It is used on a large scale in developing tissues and organs, with the aim to meet the growing demand for organ transplantation across the globe. However, the use of bioprinted products inside the human body creates biosafety concerns and can also violate religious beliefs. Additionally, the source of biomaterials being used for developing 3D bioprinted products and concerns related to waste elimination are two other major factors hindering the adoption of 3D bioprinting among individuals.

3D Bioprinting Market Dynamics

Scope of the Report

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2018–2024

Forecast units

Million/Billion (USD)

Segments covered

Component, Application, Material, End User, and Region

Geographies covered

North America, Europe, APAC, RoW (South America, Middle East, and Africa)

Companies covered

Organovo Holdings, Inc. (US), CELLINK (Sweden), Allevi Inc. (US), Aspect Biosystems Ltd. (Canada), EnvisionTEC GmbH (Germany), Cyfuse Biomedical K.K. (Japan), Poietis (France), TeVido BioDevices (US), Nano3D Biosciences, Inc. (US), ROKIT Healthcare (South Korea), Digilab, Inc. (US), regenHU (Switzerland), GeSiM (Germany), Advanced Solutions Life Sciences (US), and Regenovo Biotechnology Co., Ltd. (China).

The research report categorizes the Acoustic Wave Sensor to forecast the revenues and analyze the trends in each of the following sub-segments:

3D Bioprinting Market, By Component

  • 3D Bioprinters
    • Microextrusion bioprinting
    • Inkjet 3D Bioprinting
    • Laser-assisted Bioprinting
    • Magnetic 3D Bioprinting
    • Other technologies *
  • Bioinks
    • Natural Bioinks
    • Hybrid Bioinks
    • Synthetic Bioinks

3D Bioprinting Market, By Application

  • Research Applications
    • Drug Research
    • Regenerative Medicine
    • 3D Cell Culture
  • Clinical Application
    • Skin
    • Bone & Cartilage
    • Blood Vessels
    • Other Clinical Applications **

3D Bioprinting Market, By Material

  • Living Cells
  • Hydrogels
  • Extracellular Matrices
  • Other Biomaterials***

3D Bioprinting Market, By End User

  • Research Organization & Academic Institutes
  • Biopharmaceuticals Companies
  • Hospital

3D Bioprinting Market, By Region

  • North America
  • Europe
  • Asia Pacific (APAC)
  • RoW

Key Market Players

Organovo Holdings, Inc. (US), CELLINK (Sweden), Allevi Inc. (US), Aspect Biosystems Ltd. (Canada), EnvisionTEC GmbH (Germany), Cyfuse Biomedical K.K. (Japan), Poietis (France), TeVido BioDevices (US), Nano3D Biosciences, Inc. (US), ROKIT Healthcare (South Korea), Digilab, Inc. (US), regenHU (Switzerland), GeSiM (Germany), Advanced Solutions Life Sciences (US), and Regenovo Biotechnology Co., Ltd. (China).

Founded in 2014 and headquartered in Philadelphia, the US, Allevi Inc. (formerly known as BioBots) designs, manufactures and develops 3D tissues for use in the healthcare industry. The company’s products include 3D bioprinters, bioinks, and software, which assist in the layer-by-layer printing of 3D living tissues. The company specializes in regenerative medicine, tissue engineering, 3D bioprinting, and 3D printing. Allevi is partnering with various academic institutes, universities, and research organizations across the globe to provide training on 3D fabrication, computer-aided designing, coding, and tissue engineering to develop 3D bioprinting-related skillsets among students and researchers.   

Recent Developments

  • In 2019, Launched CELLINK SKIN Kit and CELLINK LIVER Kit. These kits provide information about the phenotype of their tissue models, which in turn helps researchers to develop reliable tissue models for cosmetic testing and drug screening.
  • In 2019, Allevi launched the Skin Bioink Kit to produce patches of skin.
  • In 2019, Organovo collaborated with Murdoch Children's Research Institute (Australia) & Ton Rabelink at Leiden University (Netherlands) to develop and expand the usage of 3D-bioprinted stem cells for the treatment of end-stage renal disease.
  • In 2019, Digilab entered into a collaboration agreement with Orgenesis, Inc. (US) to develop live cell printing processes and systems to automate the production of three-dimensional live cellular structures and tissues.

Critical questions the report answers:

  • Where will all these developments take the industry in the long term?
  • What are the upcoming trends for the 3D Bioprinting market?
  • Which segment provides the most opportunity for growth?
  • Who are the leading vendors operating in this market?
  • What are the opportunities for new market entrants?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 19)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 22)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
    2.2 Market Size Estimation
           2.2.1 Product-Based Market Estimation
           2.2.2 Primary Research Validation
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions
    2.5 Research Limitations

3 Executive Summary (Page No. - 32)

4 Premium Insights (Page No. - 36)
    4.1 3D Bioprinting Market Overview
    4.2 Market Share, By Component and Region
    4.3 Market, By Material, 2019 vs 2024 (USD Million)
    4.4 Market, By End User, 2019 vs 2024 (USD Million)
    4.5 Geographic Snapshot of the Market

5 Market Overview (Page No. - 41)
    5.1 Introduction
    5.2 3D Bioprinting Approaches
           5.2.1 Biomimicry
           5.2.2 Autonomous Self-Assembly
           5.2.3 Mini-Tissue Building Blocks
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Increasing Use of 3D Bioprinting in the Pharmaceutical and Cosmetology Industries
                    5.3.1.2 Rising Public and Private Funding to Support Bioprinting Research Activities
                    5.3.1.3 Technological Advancements in the 3D Bioprinting Industry
           5.3.2 Restraints
                    5.3.2.1 Dearth of Skilled Professionals
                    5.3.2.2 High Development & Production Costs
                    5.3.2.3 Lack of Regulatory Guidelines Governing 3D Bioprinting
           5.3.3 Opportunities
                    5.3.3.1 Rising Demand for Organ Transplants
                    5.3.3.2 Growing Awareness of 3D Bioprinting
                    5.3.3.3 Growing Demand for Regenerative Medicine & Stem Cell Research
           5.3.4 Challenges
                    5.3.4.1 Socioethical Concerns Related to the Use of 3D Bioprinted Products
                    5.3.4.2 High Cost of 3D Bioprinting
                    5.3.4.3 Process Control & Understanding

6 3D Bioprinting Market, By Component (Page No. - 49)
    6.1 Introduction
    6.2 3D Bioprinters
           6.2.1 3D Bioprinters Market, By Technology
                    6.2.1.1 Microextrusion Bioprinting
                               6.2.1.1.1 Increasing Research in the Field of Microextrusion is Fueling the Adoption of This Technology
                    6.2.1.2 Inkjet 3D Bioprinting
                               6.2.1.2.1 High Cell Viability and Low Cost have Resulted in the Increased Demand for Inkjet 3D Bioprinting
                    6.2.1.3 Laser-Assisted Bioprinting
                               6.2.1.3.1 Laser-Assisted Bioprinting is One of the Highest-Resolution Bioprinting Technologies Available in the 3D Bioprinting Industry
                    6.2.1.4 Magnetic 3D Bioprinting
                               6.2.1.4.1 Accuracy and Speed in the Formation and Processing of Cultured Tissues are the Major Advantages Associated With Magnetic 3D Bioprinting
                    6.2.1.5 Other Technologies
    6.3 Bioinks
           6.3.1 Natural Bioinks
                    6.3.1.1 Natural Bioinks are the Most Commonly Preferred Bioinks in the 3D Bioprinting Process
           6.3.2 Hybrid Bioinks
                    6.3.2.1 Hybrid Bioinks Possess High Mechanical Strength and Great Biocompatibility
           6.3.3 Synthetic Bioinks
                    6.3.3.1 Improved Mechanical Strength and Consistency Offered By Synthetic Bioinks to Drive Market Growth

7 3D Bioprinting Market, By Material (Page No. - 61)
    7.1 Introduction
    7.2 Living Cells
           7.2.1 Ethical Issues Associated With the Use of Living Cells in Organ Development to Hamper Market Growth
    7.3 Hydrogels
           7.3.1 Dynamic Properties of Hydrogels are Supporting Their Increased Use in 3D Tissue Engineering and Biomedical Applications
    7.4 Extracellular Matrices
           7.4.1 Ecm has Emerged as A Promising Tool in Tissue Engineering
    7.5 Other Biomaterials

8 3D Bioprinting Market, By Application (Page No. - 67)
    8.1 Introduction
    8.2 Research Applications
           8.2.1 Drug Research
                    8.2.1.1 Drug Research Segment to Register the Highest Growth During the Forecast Period
           8.2.2 Regenerative Medicine
                    8.2.2.1 Growing Demand for Organ Transplants to Support Market Growth
           8.2.3 3D Cell Culture
                    8.2.3.1 Rising Focus on Developing Alternatives to Animal Testing to Support Market Growth
    8.3 Clinical Applications
           8.3.1 Skin
                    8.3.1.1 Growing Number of Aesthetic and Reconstruction Surgeries to Propel Market Growth
           8.3.2 Bone & Cartilage
                    8.3.2.1 Increasing Incidence of Musculoskeletal Conditions to Drive the Demand for Bone Grafts
           8.3.3 Blood Vessels
                    8.3.3.1 Increasing Research Activities Focused on the 3D Bioprinting of Blood Vessels is the Major Factor Driving Market Growth
           8.3.4 Other Clinical Applications

9 3D Bioprinting Market, By End User (Page No. - 78)
    9.1 Introduction
    9.2 Research Organizations & Academic Institutes
           9.2.1 Research Organizations & Academic Institutes are the Fastest-Growing End Users of 3D Bioprinting
    9.3 Biopharmaceutical Companies
           9.3.1 Increasing Prevalence of Chronic Diseases to Drive the Adoption of 3D Bioprinting Among Biopharmaceutical Companies
    9.4 Hospitals
           9.4.1 3D Printing Offers A Customized Surgical Planning Tool for Hospitals

10 3D Bioprinting Market, By Region (Page No. - 83)
     10.1 Introduction
     10.2 North America
             10.2.1 US
                        10.2.1.1 The US Dominates the Global Market
             10.2.2 Canada
                        10.2.2.1 Government Initiatives to Support the Growth of the Market in Canada
     10.3 Europe
             10.3.1 Germany
                        10.3.1.1 Increasing Demand for Organ Transplants to Drive Market Growth
             10.3.2 UK
                        10.3.2.1 Increase in Funding and Grants to Support Research Activities Related to 3D Bioprinting in the UK
             10.3.3 France
                        10.3.3.1 Growing Cosmetics Industry in France to Propel the Adoption of 3D Bioprinting Technologies
             10.3.4 Rest of Europe
     10.4 Asia Pacific
             10.4.1 Japan
                        10.4.1.1 Strong Research Base and Government Support to Drive the Growth of the Market in Japan
             10.4.2 China
                        10.4.2.1 The Market in China is Projected to Register Significant Growth Owing to Rising Regenerative Medicine Research
             10.4.3 India
                        10.4.3.1 Initiatives to Raise Awareness and Develop Novel Products to Support Market Growth in India
             10.4.4 Rest of Asia Pacific
     10.5 Rest of the World
             10.5.1 Latin America
                        10.5.1.1 Growing Medical Tourism to Contribute to the Growth of the Market in the Region
             10.5.2 Middle East & Africa
                        10.5.2.1 Lack of Awareness and Underdeveloped Infrastructure to Hamper Market Growth

11 Competitive Landscape (Page No. - 142)
     11.1 Introduction
     11.2 Market Ranking Analysis
     11.3 Competitive Scenario
     11.4 Competitive Leadership Mapping
     11.5 Vendor Inclusion Criteria
     11.6 Vendor Dive
             11.6.1 Visionary Leaders
             11.6.2 Innovators
             11.6.3 Dynamic Differentiators
             11.6.4 Emerging Companies

12 Company Profiles (Page No. - 149)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     12.1 Advanced Solutions Life Sciences
     12.2 Allevi Inc.
     12.3 Aspect Biosystems Ltd.
     12.4 Cellink
     12.5 Cyfuse Biomedical K.K.
     12.6 Digilab, Inc.
     12.7 Envisiontec
     12.8 Gesim
     12.9 Nano3D Biosciences, Inc.
     12.10 Organovo Holdings, Inc.
     12.11 Poietis
     12.12 Regenhu
     12.13 Regenovo Biotechnology Co., Ltd.
     12.14 Rokit Healthcare
     12.15 Tevido Biodevices

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 174)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Available Customizations
     13.4 Related Reports
     13.5 Author Details


List of Tables (172 Tables)

Table 1 3D Bioprinting Market, By Component, 2017–2024 (USD Million)
Table 2 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 3 3D Bioprinters Market, By Region, 2017–2024 (USD Million)
Table 4 Microextrusion Bioprinting Market, By Region, 2017–2024 (USD Million)
Table 5 Inkjet Market, By Region, 2017–2024 (USD Million)
Table 6 Laser-Assisted Bioprinting Market, By Region, 2017–2024 (USD Million)
Table 7 Magnetic 3D Bioprinting Market, By Region, 2017–2024 (USD Million)
Table 8 3D Bioprinters Market for Other Technologies, By Region, 2017–2024 (USD Million)
Table 9 Bioinks Market, By Type, 2017–2024 (USD Million)
Table 10 Bioinks Market, By Region, 2017–2024 (USD Million)
Table 11 Natural Bioinks Market, By Region, 2017–2024 (USD Million)
Table 12 Hybrid Bioinks Market, By Region, 2017–2024 (USD Million)
Table 13 Synthetic Bioinks Market, By Region, 2017–2024 (USD Million)
Table 14 Market, By Material, 2017–2024 (USD Million)
Table 15 Market for Living Cells, By Region, 2017–2024 (USD Million)
Table 16 Market for Hydrogels, By Region, 2017–2024 (USD Million)
Table 17 Market for Extracellular Matrices, By Region, 2017–2024 (USD Million)
Table 18 Market for Other Biomaterials, By Region, 2017–2024 (USD Million)
Table 19 Market, By Application, 2017–2024 (USD Million)
Table 20 Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 21 Market for Research Applications, By Region, 2017–2024 (USD Million)
Table 22 Market for Drug Research, By Region, 2017–2024 (USD Million)
Table 23 Market for Regenerative Medicine, By Region, 2017–2024 (USD Million)
Table 24 Market for 3D Cell Culture, By Region, 2017–2024 (USD Million)
Table 25 Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 26 Market for Clinical Applications, By Region, 2017–2024 (USD Million)
Table 27 Market for Skin Printing Applications, By Region, 2017–2024 (USD Million)
Table 28 3D Bioprinting Market for Bone & Cartilage Printing Applications, By Region, 2017–2024 (USD Million)
Table 29 Market for Blood Vessel Printing Applications, By Region, 2017–2024 (USD Million)
Table 30 List of Ongoing Clinical Trials
Table 31 Market for Other Clinical Applications, By Region, 2017–2024 (USD Million)
Table 32 Market, By End User, 2017–2024 (USD Million)
Table 33 Market for Research Organizations & Academic Institutes, By Region, 2017–2024 (USD Million)
Table 34 Market for Biopharmaceutical Companies, By Region, 2017–2024 (USD Million)
Table 35 Market for Hospitals, By Region, 2017–2024 (USD Million)
Table 36 Market, By Region, 2017–2024 (USD Million)
Table 37 North America: 3D Bioprinting Market, By Country, 2017–2024 (USD Million)
Table 38 North America: Market, By Component, 2017–2024 (USD Million)
Table 39 North America: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 40 North America: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 41 North America: Market, By Application, 2017–2024 (USD Million)
Table 42 North America: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 43 North America: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 44 North America: Market, By Material, 2017–2024 (USD Million)
Table 45 North America: Market, By End User, 2017–2024 (USD Million)
Table 46 US: Market, By Component, 2017–2024 (USD Million)
Table 47 US: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 48 US: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 49 US: Market, By Application, 2017–2024 (USD Million)
Table 50 US: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 51 US: 3D Bioprinting Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 52 US: Market, By Material, 2017–2024 (USD Million)
Table 53 US: Market, By Component, 2017–2024 (USD Million)
Table 55 Canada: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 56 Canada: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 57 Canada: Market, By Application, 2017–2024 (USD Million)
Table 58 Canada: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 59 Canada: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 60 Canada: Market, By Material, 2017–2024 (USD Million)
Table 61 Canada: Market, By End User, 2017–2024 (USD Million)
Table 62 Europe: Market, By Country, 2017–2024 (USD Million)
Table 63 Europe: Market, By Component, 2017–2024 (USD Million)
Table 64 Europe: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 65 Europe: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 66 Europe: Market, By Application, 2017–2024 (USD Million)
Table 67 Europe: 3D Bioprinting Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 68 Europe: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 69 Europe: Market, By Material, 2017–2024 (USD Million)
Table 70 Europe: Market, By End User, 2017–2024 (USD Million)
Table 71 Germany: Market, By Component, 2017–2024 (USD Million)
Table 72 Germany: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 73 Germany: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 74 Germany: Market, By Application, 2017–2024 (USD Million)
Table 75 Germany: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 76 Germany: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 77 Germany: Market, By Material, 2017–2024 (USD Million)
Table 78 Germany: Market, By End User, 2017–2024 (USD Million)
Table 79 UK: Market, By Component, 2017–2024 (USD Million)
Table 80 UK: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 81 UK: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 82 UK: Market, By Application, 2017–2024 (USD Million)
Table 83 UK: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 84 UK: 3D Bioprinting Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 85 UK: Market, By Material, 2017–2024 (USD Million)
Table 86 UK: Market, By End User, 2017–2024 (USD Million)
Table 87 France: Market, By Component, 2017–2024 (USD Million)
Table 88 France: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 89 France: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 90 France: Market, By Application, 2017–2024 (USD Million)
Table 91 France: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 92 France: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 93 France: Market, By Material, 2017–2024 (USD Million)
Table 94 France: Market, By End User, 2017–2024 (USD Million)
Table 95 RoE: Market, By Component, 2017–2024 (USD Million)
Table 96 RoE: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 97 RoE: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 98 RoE: Market, By Application, 2017–2024 (USD Million)
Table 99 RoE: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 100 RoE: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 101 RoE: Market, By Material, 2017–2024 (USD Million)
Table 102 RoE: Market, By End User, 2017–2024 (USD Million)
Table 103 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 104 Asia Pacific: Market, By Component, 2017–2024 (USD Million)
Table 105 Asia Pacific: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 106 Asia Pacific: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 107 Asia Pacific: Market, By Application, 2017–2024 (USD Million)
Table 108 Asia Pacific: 3D Bioprinting Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 109 Asia Pacific: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 110 Asia Pacific: Market, By Material, 2017–2024 (USD Million)
Table 111 Asia Pacific: Market, By End User, 2017–2024 (USD Million)
Table 112 Japan: Market, By Component, 2017–2024 (USD Million)
Table 113 Japan: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 114 Japan: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 115 Japan: Market, By Application, 2017–2024 (USD Million)
Table 116 Japan: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 117 Japan: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 118 Japan: Market, By Material, 2017–2024 (USD Million)
Table 119 Japan: Market, By End User, 2017–2024 (USD Million)
Table 120 China: Market, By Component, 2017–2024 (USD Million)
Table 121 China: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 122 China: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 123 China: 3D Bioprinting Market, By Application, 2017–2024 (USD Million)
Table 124 China: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 125 China: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 126 China: Market, By Material, 2017–2024 (USD Million)
Table 127 China: Market, By End User, 2017–2024 (USD Million)
Table 128 India: Market, By Component, 2017–2024 (USD Million)
Table 129 India: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 130 India: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 131 India: Market, By Application, 2017–2024 (USD Million)
Table 132 India: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 133 India: 3D Bioprinting Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 134 India: Market, By Material, 2017–2024 (USD Million)
Table 135 India: Market, By End User, 2017–2024 (USD Million)
Table 136 RoAPAC: Market, By Component, 2017–2024 (USD Million)
Table 137 RoAPAC: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 138 RoAPAC: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 139 RoAPAC: Market, By Application, 2017–2024 (USD Million)
Table 140 RoAPAC: 3D Bioprinting Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 141 RoAPAC: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 142 RoAPAC: Market, By Material, 2017–2024 (USD Million)
Table 143 RoAPAC: Market, By End User, 2017–2024 (USD Million)
Table 144 Rest of the World: Market, By Region, 2017–2024 (USD Million)
Table 145 Rest of the World: 3D Bioprinting Market, By Component, 2017–2024 (USD Million)
Table 146 Rest of the World: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 147 Rest of the World: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 148 Rest of the World: Market, By Application, 2017–2024 (USD Million)
Table 149 Rest of the World: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 150 Rest of the World: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 151 Rest of the World: Market, By Material, 2017–2024 (USD Million)
Table 152 Rest of the World: Market, By End User, 2017–2024 (USD Million)
Table 153 Latin America: Market, By Component, 2017–2024 (USD Million)
Table 154 Latin America: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 155 Latin America: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 156 Latin America: Market, By Application, 2017–2024 (USD Million)
Table 157 Latin America: Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 158 Latin America: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 159 Latin America: Market, By Material, 2017–2024 (USD Million)
Table 160 Latin America: Market, By End User, 2017–2024 (USD Million)
Table 161 Middle East & Africa: Market, By Component, 2017–2024 (USD Million)
Table 162 Middle East & Africa: 3D Bioprinters Market, By Technology, 2017–2024 (USD Million)
Table 163 Middle East & Africa: 3D Bioinks Market, By Type, 2017–2024 (USD Million)
Table 164 Middle East & Africa: Market, By Application, 2017–2024 (USD Million)
Table 165 Middle East & Africa: 3D Bioprinting Market for Research Applications, By Type, 2017–2024 (USD Million)
Table 166 Middle East & Africa: Market for Clinical Applications, By Type, 2017–2024 (USD Million)
Table 167 Middle East & Africa: Market, By Material, 2017–2024 (USD Million)
Table 168 Middle East & Africa: Market, By End User, 2017–2024 (USD Million)
Table 169 Product Launches & Approvals
Table 170 Collaborations
Table 171 Expansions
Table 172 Acquisitions


List of Figures (25 Figures)

Figure 1 3D Bioprinting Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primaries
Figure 4 Research Methodology: Hypothesis Building
Figure 5 Market Size Estimation: Overall 3D Bioprinting Market
Figure 6 Data Triangulation Methodology
Figure 7 Market Share, By Component, 2019 vs 2024
Figure 8 Market, By Application, 2019 vs 2024 (USD Million)
Figure 9 Market Share, By Material, 2019 vs 2024
Figure 10 Market, By End User, 2019 vs 2024 (USD Million)
Figure 11 Geographical Snapshot of the Market
Figure 12 Technological Advancements in 3D Bioprinters and Biomaterials to Drive Market Growth
Figure 13 North America is the Largest Regional Market for 3D Bioprinters and Bioinks
Figure 14 Living Cells Segment to Hold the Major Share of the Market During the Forecast Period
Figure 15 Research Organizations & Academic Institutes Will Register the Highest CAGR During the Forecast Period
Figure 16 China to Register the Highest CAGR During the Forecast Period
Figure 17 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 North America: Market Snapshot
Figure 19 Europe: Market Snapshot
Figure 20 Asia Pacific: Market Snapshot
Figure 21 Global Market Ranking, By Key Player, 2018
Figure 22 Competitive Leadership Mapping (Overall Market), 2018
Figure 23 Competitive Leadership Mapping (SME/Start-UPS), 2018
Figure 24 Cellink: Company Snapshot
Figure 25 Organovo Holdings, Inc.: Company Snapshot

The study involved four major activities in estimating the current size of the 3D bioprinting market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of the segments and subsegments.

Secondary Research

This research study involved the extensive use of secondary sources, directories, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva), along with government databases, which were used to identify and collect information for this method-based, market-oriented, and commercial study of the market.

In-depth interviews were conducted with various primary respondents that mainly include key industry participants, medical practitioners, subject-matter experts (SMEs), C-level and D-level executives of key market players, and industry consultants to obtain and verify critical qualitative and quantitative information as well as to assess prospects of the market.

Primary Research

Extensive primary research was conducted after acquiring knowledge about the 3D bioprinting market scenario through secondary research. A significant number of primary interviews were conducted with both the demand (healthcare providers, research institutes, physicians, and healthcare professionals) and supply sides (developers, manufacturers, and distributors of 3D bioprinting products). The primaries interviewed for this study include experts from the 3D bioprinting industry (such as CEOs, VPs, directors, sales heads, and marketing managers of tier 1, 2, and 3 companies engaged in offering 3D bioprinting products across the globe), purchase managers in healthcare provider organizations, administrative heads of biopharmaceutical companies, stem cell banks, CROs, heads of research and academic institutes, and scientists.

Around 60% and 40% primary interviews were conducted with the supply and demand sides, respectively. A robust primary research methodology has been adopted to validate the contents of the report and to fill gaps. Telephonic and e-mail communications were adopted to conduct interviews (questionnaires were designed and sent to primary participants as per their convenience). The following is the breakdown of primary respondents:

3D Bioprinting Market Dynamics

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

A detailed market estimation approach was followed to estimate and validate the size of the 3D bioprinting market and other dependent submarkets, as mentioned above. The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. The research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights (both quantitative and qualitative trends) on the market. All percentage shares split, and breakdowns were determined by using secondary sources and verified through primary sources. All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report. The research methodology used to estimate the market size includes the following:

  • Product mapping of various manufacturers for each component type of 3D bioprinting at the regional and country-level 
  • Relative adoption pattern of each 3D bioprinting technology among key end-users at the regional and country-level
  • Detailed primary research to gather quantitative information related to segments and subsegments at the region and country-level
  • Detailed secondary research to gauge prevailing market trends at the region and country-level

Data Triangulation

After arriving at the overall market size of the 3D bioprinting industry from the market estimation approach explained above, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact market value data, data triangulation, and market breakdown methodology methods were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand- and supply-side analysis.

Report Objectives

  • To define, describe, and forecast the 3D bioprinting market based on component, application, material, end-user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze the micro-markets concerning individual growth trends, prospects, and contributions to the market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the revenue of the market segments for four main regions, namely, North America, Europe, Asia Pacific, and Rest of the World.
  • To strategically profile the key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as new product launches; agreements, partnerships, and joint ventures; mergers & acquisitions; business expansions and research & development activities in the market          

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present 3D bioprinting market report:

Product Analysis

Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Report Code
BT 4971
Published ON
Sep, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the 3D Bioprinting Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home